Akari Therapeutics, Plc Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Akari Therapeutics, Plc shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2015-09-30 was -$32.00K.
- Akari Therapeutics, Plc shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2015-06-30 was $49.00K.
- Akari Therapeutics, Plc shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2015-03-31 was $59.00K.
- Akari Therapeutics, Plc shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2014 was $412.00K.
- Akari Therapeutics, Plc shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2012 was $2.00K.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2015-09-30 | -$32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-23 | |
| 2015-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | |
| 2015-03-31 | $59.00K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $412.00K 10-K · filed 2015-02-11 | |
| 2012-12-31 | $2.00K 10-K · filed 2015-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |